KIDA T, YAMAZAKI A, NAKAMURA T, KOBAYASHI K, YOSHIMOTO S, MAEDA S, NAKAGAWA T, NISHIMURA R, MURATA T. Comprehensive profiling of lipid metabolites in urine of canine patients with liver mass.
J Vet Med Sci 2022;
84:1074-1078. [PMID:
35675982 PMCID:
PMC9412059 DOI:
10.1292/jvms.22-0191]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Fatty acids are an essential component of mammalian bodies. They go through different
metabolic pathways depending on physiological states and inflammatory stimuli. In this
study, we conducted a liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based
comprehensive analysis of lipid metabolites in urine of canine patients with liver mass.
There were significant differences in quantity of some lipid metabolites that may be
closely associated with the disease and/or general inflammatory responses, including
increased metabolites of prostaglandin E2 and/or PGF2α. We
demonstrated that our approach of profiling lipid metabolites in the urine is useful in
gaining insights into the disease. These findings may also have an application as a
screening test or a diagnosis tool for canine liver mass.
Collapse